Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: May 4, 2000
Last updated: September 24, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)